Dicerna Pharmaceuticals, Inc., A Novo Nordisk Company
Clinical trials sponsored by Dicerna Pharmaceuticals, Inc., A Novo Nordisk Company, explained in plain language.
-
Promising drug may protect kidneys in kids with rare oxalate disorder
Disease control CompletedThis study tested a monthly injection called nedosiran in 27 children from birth to 11 years old with primary hyperoxaluria, a rare condition that causes harmful oxalate buildup and kidney damage. The goal was to see if the drug safely lowers oxalate levels in the urine. Early re…
Phase: PHASE2 • Sponsor: Dicerna Pharmaceuticals, Inc., a Novo Nordisk company • Aim: Disease control
Last updated Jun 27, 2026 12:08 UTC
-
New Liver-Targeting drug could help curb alcohol cravings
Disease control CompletedThis early-stage trial tested a new drug called DCR-AUD in 16 healthy adults who are social drinkers. The drug is designed to reduce the effects of alcohol by targeting the liver. The main goal was to check safety and how the body processes the drug, not to treat alcohol use diso…
Phase: PHASE1 • Sponsor: Dicerna Pharmaceuticals, Inc., a Novo Nordisk company • Aim: Disease control
Last updated Jun 27, 2026 08:11 UTC
-
Experimental drug DCR-STAT3 tested in patients with stubborn cancers
Disease control CompletedThis early-stage trial tested an experimental drug called DCR-STAT3 in 26 adults with solid tumors that had stopped responding to standard treatments. The main goal was to check the drug's safety and how the body processes it. Researchers gave increasing doses to find the best an…
Phase: PHASE1 • Sponsor: Dicerna Pharmaceuticals, Inc., a Novo Nordisk company • Aim: Disease control
Last updated Jun 27, 2026 07:52 UTC